Skip to main content

and
  1. No Access

    Article

    Update on Phase I/II Breast Cancer Prevention Trials

    The greatest success in breast cancer prevention has been with two agents, tamoxifen and raloxifene, both of which are approved by the US Food and Drug Administration (FDA) for the risk reduction of invasive b...

    Brandy M. Heckman-Stoddard, Kathleen A. Foster in Current Breast Cancer Reports (2011)